Evidence map›Paper›PMID 39229967›Full record

ArticleFuture oncology (London, England)2024

Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients.

Laura Tookman, Clare Green, Katy Leonard, Victoria Clare, Nafisa Patel, Farah Dunlop, Stephen McCormack, Hilary Ellis, Joanna de Courcy, Lauren Bateman and 1 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Laura TookmanImperial College Healthcare NHS Trust, London, United Kingdom.
Clare GreenUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Katy LeonardGlaxoSmithKline, Middlesex, UK.
Victoria ClareOvacome, London, UK.
Nafisa PatelLeicester Royal Infirmary Hospital, Leicester, UK.
Farah DunlopGlaxoSmithKline, Middlesex, UK.
Stephen McCormackGlaxoSmithKline, Middlesex, UK.ORCID 0000-0003-3264-7733
Hilary EllisAdelphi Real World, Bollington, UK.ORCID 0000-0002-6334-9045
Joanna de CourcyAdelphi Real World, Bollington, UK.ORCID 0000-0001-9707-0387
Lauren BatemanAdelphi Real World, Bollington, UK.
Jane BorleyRoyal Cornwall Hospitals NHS Trust, Truro, UK.

Funding

GlaxoSmithKline
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Ovarian EpithelialHealth PersonnelOvarian NeoplasmsQuality of LifeAdultAgedCost of IllnessCross-Sectional StudiesFemaleHumansMiddle AgedNeoplasm StagingSurveys and QuestionnairesTime-to-TreatmentUnited Kingdomadvanced ovarian cancerburdendiagnosispatient-reported outcomesquality of lifeReal-world evidencetreatment pathways

Identifiers

PMID39229967
PMCPMC11485836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.